CAC Tied to Cardiovascular Risk During Radiation Therapy for NSCLC

MONDAY, Feb. 14, 2022 -- The burden of coronary artery calcium (CAC) may help predict the risk for major adverse cardiovascular events (MACE) during radiation treatment for non-small cell lung cancer (NSCLC), according to a study presented at the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news